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Regions of hypoxia, or low oxygen tension, are known to exist
within tumours (Raleigh et al, 1996; Brown and Giaccia, 1998;
Dewhirst, 1998). Since radiotherapy and some forms of
chemotherapy are less effective at killing cancer cells in hypoxic
environments, much effort has been directed toward identifying
tumours containing such regions. Measurement of oxygen tension
by needle electrodes in lymph node metastasis of cancer of the
head and neck found that radiation was less effective at inducing
regression when the lymph nodes were hypoxic (Gatenby et al,
1988) and such measurements have been reported to identify
patients with poor locoregional tumour control (Nordsmark et al,
1996). Similar work in advanced cancer of the uterine cervix
(Hockel et al, 1993, 1996; Fyles et al, 1998; Hockel and Vaupel,
1998) showed that increased levels of hypoxia in the primary
tumour mass correlated with poorer treatment outcome. These
results suggested that hypoxia in cervical cancers correlated with a
greater likelihood of both local failure and nodal metastasis.
Metastases were also found to be more frequent in patients with
the most hypoxic soft tissue sarcoma of the extremities (Brizel
et al, 1996). Furthermore, exposure of cancer cells to hypoxia
(Young et al, 1988; Jang and Hill, 1997) and hypoxia-induced
increases in vascular endothelial growth factor (VEGF) secretion
have been associated with an increased metastatic ability
(Danielsen and Rofstad, 1998).
VEGF is the most selective vascular endothelial cell mitogen
known (Dvorak et al, 1995). In cancer cells, the four VEGF
isoforms which have been most frequently described contain 121,
165, 189 and 206 amino acids (Tischer et al, 1991). In some
studies, increased intra-tumoural VEGF mRNA and protein has
been associated with poor prognosis (Berger et al, 1995; Toi et al,
1995), increased metastasis (Brown et al, 1995; Takahashi et al,
1995), and increased microvessel density (Guidi et al, 1995; Toi et
al, 1995; Fontini et al, 1997). Antibodies directed towards VEGF
can inhibit angiogenesis and the proliferation of cancer cells in
vivo (Kim et al, 1993; Kondo et al, 1993). Cancer cells constitu-
tively produce VEGF (Dvorak et al, 1995) and can up-regulate
its expression under hypoxic stress (Shweiki et al, 1992) via the
transcription factor hypoxia-inducible factor 1 (Forsythe et al,
1996) and by stabilization of the mRNA (Levy et al, 1996, 1998).
The qualitative relationship between oxygen level and VEGF
up-regulation has been examined in a variety of different tumour
systems but has not been quantitatively documented in most of the
studies performed (Shweiki et al, 1992; Minchenko et al, 1994;
Leith and Michelson, 1995; Mukhapadhyay et al, 1995). The
purpose of the present work was to examine the relationship
between VEGF mRNA level and oxygen concentration in detail
and to determine the extent of its variation between different
tumour cells of similar histopathological type. Cell lines derived
from human cancer of the uterine cervix were chosen for the
study based on the abundance of clinical data relating tumour
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treatment outcome and the possibility that VEGF mRNA might be
usable as a marker for relevant levels of hypoxia in such tumours.
VEGF mRNA rather than protein was chosen for study because it
is localized to the cell which is under hypoxic stress and is thus
able to localize this environment.
MATERIALS AND METHODS
Cells
Cell lines used in the experiments were SiHa, ME-180, and HeLa
which are derived from human cancer of the uterine cervix. The
SiHa and ME-180 cells were obtained from ATCC (American
Type Culture Collection, Manassas, VA, USA), while the HeLa
cells were obtained from the laboratory of Dr Michael Rauth at
OCI/PMH where they had been grown for many years. These
cells were grown in plastic tissue culture flasks (Gibco BRL,
Burlington, ON, Canada) in a-minimal essential medium
(a-MEM; Gibco BRL, Burlington, ON, Canada) plus 10% fetal
bovine serum (FBS; Wisent, Quebec, Canada) plus antibiotics for
SiHa and HeLa and in McCoy’s 5A medium plus 10% FBS plus
antibiotics for ME-180. The cells were grown to about 70%
confluence, then trypsinized, counted and a volume containing
3 ´ 106 cells was spun down at 130 g at 4°C. The supernatant was
then poured off, leaving a cell pellet which was resuspended in
the remaining medium, approximately 50 ml, and introduced into
the vials within 10 min of centrifugation as described below.
Oxygenation
The apparatus used for accurate control of the level of oxygen
exposure of the cells has been fully described (Whillans and
Rauth, 1980). Briefly, the apparatus consisted of a 37°C water bath
into which a set of glass vials, each containing a small magnetic
stir bar and 10 ml of medium, was placed. The medium was stirred
at 200 rpm and humidified gas was flowed through an inlet in the
stopper for 90 min to achieve an equilibrium between the oxygen
(O2) in the gas phase and the liquid medium. The small volume of
medium containing the cells was introduced into each of the vials
(final concentration: 3 ´ 105 cells ml–1) by sterile Pasteur pipet
after the 90-min gassing period and the gassing and stirring was
continued. At defined time intervals later, a vial was removed from
the 37°C water bath and placed on ice prior to total RNA extrac-
tion. Gases containing O2 concentrations of 21% (air), 6.25%,
4.85%, 3.46%, 2.11%, 1.57%, 1.00%, or 0% (< 10 ppm) each with
5% carbon dioxide (CO2) and balance N2 were used. The composi-
tion of the gases was analysed to be within 2% or better of the
value given by the supplier (Praxair, Toronto, ON, Canada) and
was confirmed in our laboratory.
Each cell line was checked twice for the occurrence of cellular
aggregation after 4 h of stirring. No cellular aggregates were seen.
The effect of the stirring on the cells was checked after 4 h of stir-
ring in both N2 and air environments by plating the cells in tissue
culture dishes for colony formation. Plating efficiencies ranged
from 50 to 80% of that found for cells which were not stirred (data
not shown). The pH of the stirred cell suspension was checked for
each cell line and was found to be unchanged at about 7.5
throughout the length of a 4-h gassing period.
Oxygen measurements
Since the cells can be expected to consume some of the oxygen
and hence influence the level of oxygen to which they are exposed,
a Clark-type polarographic electrode (Marshall et al, 1986) was
used to measure O2 concentration in the cell-containing medium.
A glass vial and stopper, into which an extra hole was cut to
accommodate the oxygen sensor, was prepared as above. The
sensor was first calibrated for O2 concentration using the above
series of gases. A total of 3 ´ 106 cells was introduced into stirred
medium, as described above, and the resulting O2 concentration
was measured once a stable signal indicating equilibration had
been achieved, a process requiring approximately 5 min. Results
obtained for the different mixtures are shown in Table 1.
RNAase protection assay
After exposure to gassing, the cells were spun into a pellet at 200 g
at 4°C for 5 min, resuspended in phosphate-buffered saline (PBS),
and repelleted as before. Total RNA was then extracted with Trizol
(Gibco BRL, Burlington, ON, Canada) using the manufacturer’s
protocol and stored at –70°C until analysis. An RNAase protection
assay was used to quantitate VEGF and 36B4 mRNA levels (Zinn
et al, 1983). The 36B4 mRNA codes for an acidic ribosomal
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Table 1 Oxygen concentration in mM measured in medium containing 3 ´ 105 cells ml–1 of one of the cell lines compared to
the oxygen tension in the overlying gas in mmHg and to the expected oxygen concentration in the medium in the absence
of cells in mM
Ambient oxygen Expected SiHa cells ME-180 cells HeLa cells
tension (mmHg) oxygen ± s.e.m. (mM) ± s.e.m. (mM) ± s.e.m. (mM)
[% O2 in gassing concentration
mixture] (mM)
7.5 [1.00] 10.6 2.1 ± 0.7a 5.5 ± 1.3a 6.4 ± 1.0a
11.2 [1.57] 15.9 8.9 ± 1.1 10.2 ± 1.4 10.8 ± 0.6
15.1 [2.11] 21.4 16.5 ± 0.8 14.9 ± 1.6 16.8 ± 0.4
24.8 [3.46] 35.2 30.7 ± 2.1 27.1 ± 0.8 28.5 ± 2.4
34.7 [4.85] 49.3 46.1 ± 5.1 – 40.3 ± 1.8
44.8 [6.25] 63.6 59.5 ± 1.4 53.7 ± 2.0 52.0 ± 1.4
141.7 [air] 200.3 194.3 ± 3.8 196.0 ± 5.4 192.6 ± 4.3
aOxygen concentration in medium containing SiHa cells significantly different from medium containing ME-180 cells (P = 0.01)
or HeLa cells (P < 0.001).protein (Laborda, 1991) and served as a loading control. Briefly,
riboprobes were purified on a 6% polyacrylamide/urea gel then
eluted overnight at 37°C in elution buffer (0.5 M EDTA, 0.1%
sodium dodecyl sulphate (SDS), 0.1 M EDTA), precipitated and
their radioactivity quantified. The probes were hybridized in
excess to 10 mg of total RNA overnight at 52°C. Samples were
digested with 40 mg ml–1 of RNAase and 2 mg ml–1 of RNAase T1
for 30 min at 30°C. Ten microlitres of 20% SDS and 50 mg of
proteinase K were then added, followed by incubation for 15 min
at 37°C, phenol–chloroform extraction, and ethanol precipitation
with glycogen. The protected probes were then resolved on a 6%
polyacrylamide/urea gel and quantitated on a PhosphorImager
(Molecular Dynamics, Sunnyvale, CA, USA).
Probes
A probe for detecting VEGF mRNA was generated using the StyI
fragment (nucleotides 99–352) (Tischer et al, 1991) obtained from
the cDNA for VEGF165 (kind gift of Dr Keith Laderoute,
Stanford Research Institute). The fragment was blunted and
subcloned into the SmaI site of the pBluescript II KS(2) cloning
vector, which was then linearized with XbaI. Correct orientation of
the insert was confirmed with the production of a 121-bp DraII
fragment. The 32P-radiolabelled antisense riboprobe, containing
253 nucleotides was capable of recognizing all four cancer-related
isoforms. It was transcribed using a T7 RNA polymerase.
A cloning vector containing the cDNA for 36B4 (Laborda,
1991) (kind gift of Dr Linda Penn, Ontario Cancer Institute) was
linearized with EcoRV. The 32P-radiolabelled antisense riboprobe
containing 63 nucleotides, was transcribed using an SP6 RNA
polymerase. For all the results presented, the amount of VEGF
mRNA was normalized to the amount of 36B4 mRNA detected in
the same lane on the polyacrylamide gel. A comparison of the
36B4 levels in cells gassed with 95% N2–5% CO2 for 0 h or 4 h,
collected over 48 experiments for all three cell lines, showed no
evidence of an effect of hypoxic exposure on the expression level
(paired t-test, P = 0.69).
Statistical analysis
The curves for VEGF mRNA upregulation as a function of oxygen
concentration were fitted to a logistic function using the
Levenburg–Marquardt algorithm in the Origin 5.1 software
package (Microcal, Northampton, MA, USA) as described in the
text. The Km values for VEGF mRNA up-regulation and the VEGF
mRNA half-lives were compared in a two-tailed test using the Z
statistic. Comparisons of oxygen concentrations in cell-containing
medium were made using a two-tailed Student’s t-test. In both
cases significance was determined by a P-value less than 0.05.
RESULTS
Net increase in VEGF mRNA levels under long-term
anoxia
Initially we examined the time course of the increase in VEGF
mRNA levels during exposure to anoxia (< 10 ppm O2). Cells
were placed in a vial containing medium which had been equili-
brated either with N2–5% CO2 (anoxic) or air–5% CO2. The cells
were then exposed to this environment for up to 12 h with samples
taken at 0, 2, 4, 8 and 12 h for analysis of mRNA levels. Figure 1
shows the results for each cell line under anoxic and air conditions.
The degree of VEGF up-regulation was normalized to time 0 h for
each cell line. The points represent the mean (± s.e.m.) of at least
three independent experiments. By 4 h, VEGF mRNA in ME-180
cells had reached its maximum level. The HeLa line showed a
gradual up-regulation of VEGF mRNA over the 12 h; however,
the degree of up-regulation is similar to that in ME-180 cells. In
both these cell lines only slight changes in VEGF mRNA levels
occurred over 12 h under air conditions. In the SiHa cells the
VEGF mRNA level reached a plateau after 8 h of anoxia.
However, there was also an increase in the control air conditions
particularly after 2 h, presumably as a result of the stress of being
in the stirred suspension. Thus, a plateau for SiHa cells likely
occurs earlier than 8 h.
Analysis of VEGF mRNA levels in cells exposed to
different oxygen concentrations
This set of experiments was performed to determine in detail the
range of oxygen concentration over which VEGF mRNA is up-
regulated. Cells were gassed with various oxygen concentrations
using groups of three vials, that included a vial which contained
cells exposed to the oxygen concentration in question, a vial
containing cells which were gassed with 95% N2–5% CO2 (the
positive control), and a vial containing cells gassed with 95% air–
5% CO2 (the negative control). Since the results in Figure 1
suggest that much of the effect of the hypoxic exposure occurred
in the first 4 h of gassing, the cells were sampled at time 0, 2 and 4
h after the start of the gassing and total RNA extracted. The ratio
of VEGF mRNA to 36B4 mRNA at 2 and 4 h was normalized to
the ratio at 0 h. For each of the three cell lines, measurements at
each of the above oxygen concentrations were performed at least
in triplicate.
Figure 2A shows the relative VEGF mRNA level as a function
of oxygen concentration for ME-180 cells measured at 2 and 4 h.
Figures 2B and 2C show the 2- and 4-h data for SiHa and HeLa
cells respectively. The data were fitted to a logistic function and
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Figure 1 Relative VEGF mRNA level in cells exposed to anoxia or air in
stirred cell suspension as a function of time. Solid symbols with solid lines
indicate exposure to anoxia. Open symbols with dashed lines indicate
exposure to air. The absolute ratio of VEGF mRNA to 36B4 mRNA at time
0 h (mean ± s.e.m.) is 3.3 ± 0.3 for SiHa cells, 3.0 ± 0.3 for ME-180 cells,
and 1.4 ± 0.1 for HeLa cellsOxygen dependence of VEGF mRNA 1521
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the oxygen concentration at which half-maximal up-regulation
occurs was determined. During curve fitting, the maximum and
minimum values were fixed based on observations of the data. The
minimum values were the lowest points at the highest oxygen
concentration with the single exception of 4-h data for the HeLa
cells where an average of the values at the two highest oxygen
concentrations was used. For the ME-180 cell line, the maximum
level was chosen to be the highest single point (at 5.5 mM) in the 2-
h and 4-h data set. In the case of the SiHa cells, the maximum
value was an average of the two values (at 2.1 mM and 8.9 mM)
which appeared to be on the upper plateau. For the SiHa and ME-
180 cell lines, this calculation did not include the 95% N2–5% CO2
point because it was generally below the maximum value observed
at intermediate oxygen levels and it is possible that a cell’s ability
to produce mRNA may be compromised at very low oxygen
concentrations. This effect was not seen in the HeLa cell line,
consequently for the HeLa cells, the maximum value was chosen
to be the relative VEGF mRNA level at the anoxic point. Figure 2
indicates that the lines generated are generally a good fit to the
data. Modifying these choices of maximum levels (or minimum
levels for the HeLa 4-h data) modified slightly the calculated Km
values but did not affect the conclusions drawn from the data.
The data shows that at high oxygen concentrations, i.e. above
60 mM, there is relatively little upregulation of VEGF mRNA. In
the region between 10 mM and 50 mM, there is a dramatic increase
in the amount of VEGF mRNA present in the cell. Below 10 mM,
the up-regulation of VEGF mRNA appears to reach maximal
levels. There may be a trend towards VEGF mRNA levels which
are lower than maximal at very low oxygen levels, but this does
not reach statistical significance.
Table 2 shows the oxygen concentrations which produce half-
maximal upregulation at the 2- and 4-h time points. There were no
statistical differences between the 2- and 4-h values for the SiHa
and ME-180 cell lines. The difference between 2- and 4-h values
for the HeLa cell line was significant (P < 0.0001) and remained
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Figure 2 Relative VEGF mRNA level as a function of oxygen
concentration. Data for ME-180 cell line (A), SiHa cell line (B) and HeLa cell
line (C) showing VEGF mRNA levels as measured at 2 h (n n) and 4 h (n)
Table 2 Oxygen concentrations which cause half-maximal up-regulation of
VEGF mRNA at 2 and 4 h and half-lives in presence of air
Cell line 2 h (mM ± 1 s.e.m.) 4 h (mM ± 1 s.e.m.) Half-life (min ± 1 s.e.m.)
SiHa 29.1 ± 6.1 27.0 ± 5.7 59.8 ± 5.8
ME-180 18.7 ± 6.9 16.8 ± 3.3 44.4 ± 7.2
HeLa 24.9 ± 0.7 13.0 ± 1.8 44.5 ± 6.3
Oxygen concentration (mM)
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Figure 3 Percentage change in VEGF mRNA level in the SiHa and HeLa
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so with alternate choices for maximum and minimum. No statis-
tical differences were seen among the 2-h values for the three cell
lines. The 4-h value for the SiHa cell line and the HeLa cell line
was statistically different (P = 0.01) and remained so with recalcu-
lation using alternate choices of maximum and minimum. Figure 3
illustrates this difference by showing the percentage change in
VEGF mRNA levels in SiHa and HeLa cells at 4 h as a function of
oxygen concentration. The data for ME180 cells at 4 h lies inter-
mediate between these two curves and has been omitted for clarity.
Determination of VEGF mRNA half-life in the presence
of oxygen
In the final series of experiments we examined the stability of the
VEGF mRNA when the cells were returned from anoxic exposure
(< 10 ppm O2) to exposure to air. The cells were placed in vials
equilibrated with either 95% N2–5% CO2 or 95% air–5% CO2, and
stirred in their respective environments for 3 h, then one vial of
each was sampled and the remaining 95% N2–5% CO2 vials were
switched to gassing with 95% air–5% CO2. The cell-containing
medium required 4 min to reach an oxygen concentration of 100
mM at which point the effect of hypoxia on upregulation of VEGF
mRNA was considered to be negligible. The vials were subse-
quently sampled at 1, 2 and 3 h. The level of VEGF mRNA in the
N2-gassed vials was divided by the values in the air controls and
this ratio plotted against time. Figure 4 shows the results for ME-
180 cells, fitted to an exponential decay curve. Similar results were
obtained for SiHa and HeLa cells (data not shown). The half-life
for reduction of the mRNA levels was determined for each cell
line from the fitted exponential decay curve. The values obtained
are shown in Table 2. These data suggest a similar decay time for
all three cell lines. The calculated half-lives of the VEGF mRNA
in ME-180 cells, HeLa cells and SiHa cells are consistent with
values reported in the literature: approximately 40 min in rat
glioblastoma (Stein et al, 1995) and 43 ± 6 min in rat pheochromo-
cytoma cells (Levy et al, 1996).
DISCUSSION
In the present study we examined the effect of different oxygen
concentrations on the upregulation of VEGF mRNA in three
cervical cancer cell lines. One aim of the experiments was to
examine whether the presence of high levels of VEGF mRNA
could serve as a surrogate marker for radiobiological hypoxia. A
number of different cell lines were studied using the same tech-
niques to determine if differences existed. VEGF mRNA was
chosen for study over VEGF protein because the mRNA stays
localized to the cell which is under hypoxic stress and is thus able
to localize this environment.
Figure 1 shows that the rate of the hypoxia-induced increase in
the relative level of VEGF mRNA differs amongst cell lines. To
our knowledge, the increase in the relative level of VEGF mRNA
associated with a stirred cell suspension, as was the case especially
for the SiHa cell line, has not been described before. The physical
stress of stirring, alteration of the cell shape while in suspension,
or the loss of cell contact with its extracellular matrix may all
contribute to this effect. A cancer cell may be exposed to similar
stresses in the metastatic process. The increased vascular perme-
ability caused by VEGF, partly due to the opening of endothelial
intercellular junctions large enough to allow the passage of
erythrocytes (Roberts and Palade, 1995), might allow a metastatic
cell producing it to penetrate a microvascular wall more easily.
The oxygen concentrations at which the VEGF mRNA is half-
maximally up-regulated (Km value) appear to be cell line specific
(Figure 2 and Table 2), indicating differences in the ability of
cervical cancer cell lines to react to hypoxic stress. Differences in
the sensitivity of the oxygen sensor within the cell, thought to be a
haem protein (Bunn and Poyton, 1996), could explain these differ-
ences. One possible explanation could be the existence of intra-
cellular oxygen gradients (Boag, 1970) which result in the oxygen
concentration at the oxygen sensor being lower than that in the
media surrounding the cells, thus triggering VEGF mRNA produc-
tion at higher measured oxygen concentrations. At oxygen concen-
trations in the range of the Kms for each of the cell lines the oxygen
consumption appears to be equivalent (Table 1). However, at the
lowest oxygen concentrations the SiHa cells appear to have a
higher rate of oxygen consumption than HeLa and ME-180 cells
(Table 1). Since the exact location of this sensor is not known
(Bunn and Poyton, 1996), the significance of these differences
cannot be assessed.
The observed shift in the Km value to a lower oxygen concentra-
tion at 4 h (vs 2 h) for the HeLa cell line may indicate a change in
the cell line’s ability to react to hypoxic stress with time.
The oxygen dependence of HIF-1 protein production and DNA-
binding activity has been studied previously using the HeLa cell
line (Jiang et al, 1996). The half-maximal value for these two
activities, measured after 4 h of treatment, occurred between 1.5
and 2% oxygen (15–20 mM). This value is close to that observed
for HeLa cells in the present study (13.0 ± 1.8 mM). In deriving
their value, Jiang et al circumvented the problem of oxygen
gradients created by cellular respiration by inhibiting oxidative
phosphorylation with potassium cyanide (KCN). The presence of
KCN altered the HIF-1 subunit levels, however the oxygen value
associated with the half-maximal HIF-1 level in the presence or
absence of KCN were about the same.
A number of other studies have shown up-regulation of VEGF
mRNA with hypoxia, but in most cases have not examined its
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Figure 4 Relative VEGF mRNA level in ME-180 cells exposed to anoxia for
3 h, then exposed to air as a function of timeOxygen dependence of VEGF mRNA 1523
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dependence on oxygen concentration quantitatively (Shweiki et al,
1992; Minchenko et al, 1994; Mukhapadhyay et al, 1995). To our
knowledge only one study has examined the oxygen concentration
dependence of VEGF production in cells (Leith and Michelson,
1995). In this study VEGF protein production was examined in
two colon cancer cell lines exposed to a range of oxygen concen-
trations. Similar VEGF protein secretion rates were observed at
oxygen concentrations in the gas phase below 0.3%. The apparatus
for control of oxygen concentration consisted of cells in mono-
layer culture with an overlying 2.3-mm layer of medium over
which flowed gas of accurately known oxygen concentration.
With this depth of medium, a significant oxygen gradient due to
cellular respiration would exist (Koch, 1984) and would result in
uncertainty in the actual oxygen concentration to which the cells
were exposed. In fact, the cell density was similar to that in the
present study (2.8 ´ 105 vs 3.0 ´ 105 cells ml–1) where a decrease
in oxygen concentration due to cellular respiration was clearly
demonstrated (Table 1). The present study was conducted in a
well-controlled environment with direct oxygen measurements
and specifically measured the Km value for upregulation of the
mRNA, not protein, and showed that differences in that value may
exist in cells of the same cancer type.
Interestingly, the Km values that we have measured for VEGF
up-regulation are similar to the oxygen concentrations which stim-
ulate the ability of endothelial cells to form capillary networks
(Helmlinger and Jain, 1998). They are also low enough that, if
oxygen concentration were the only deteminant for VEGF produc-
tion, most tumours should contain areas which are hypoxic enough
(Vaupel and Hockel, 1998) to have large areas which stain for
VEGF. In-situ hybridization which showed that VEGF mRNA was
found primarily in cells adjacent to areas of necrosis (Shweiki
et al, 1992) or tumour cell nests (Plate et al, 1994) did not attempt
to quantitate the oxygen concentration within the tumour. To what
extent the observed variation in VEGF staining for protein or
mRNA in human tumours may reflect technical factors is not
known (Senger et al, 1993; Guidi et al, 1995).
One possible use for a detailed understanding of the oxygen
dependence of VEGF mRNA up-regulation would be as a marker
for hypoxia, especially radiobiological hypoxia. Oxygen acts as
a radiation sensitizer and the Km value for half maximum radio-
sensitization is usually regarded as being in the range of 2–
5 mmHg (3–7 mM) (Chapman et al, 1974; Vaupel et al, 1989).
However, recent studies in our laboratory with the SiHa and
ME-180 cell lines used in this study suggest much higher values
(Vukovic et al, 1998) similar to the Km values for VEGF mRNA
upregulation reported here. Thus, such up-regulation may prove
useful as a marker for radiobiologic hypoxia.
Physiologic conditions other than hypoxia are known to cause up-
regulation of VEGF. Low glucose levels in the presence of oxygen
(Shweiki et al, 1995) and low pH (Xie et al, 1998) can both increase
VEGF levels in vitro. This complicates the interpretation of changes
in the level of VEGF in vivo. The levels of hypoxia required for its
upregulation in vivo need to be established. This might be done with
the use of a marker for hypoxia such as the 2-nitroimidazole EF-5,
which has a Km value for binding of about 1 mmHg (1.5 mM) (Koch
et al, 1995). The amount of EF-5 bound in cells can be used to deter-
mine their oxygen level during exposure to EF-5 and seems to corre-
late with VEGF protein expression in spheroids (Waleh et al, 1995);
however, it has been recently reported that pimonidazole binding
does not correlate with VEGF protein expression in human squa-
mous cell carcinomas (Raleigh et al, 1998).
Increased VEGF production by a cell may enhance its ability to
form metastases. Evidence exists linking increased production of
VEGF in rodent tumour cells (Jang and Hill, 1997), human
melanoma cells (Claffey et al, 1996; Slaven et al, 1997; Danielsen
and Rofstad, 1998), and human fibrosarcoma cells (Goldman et al,
1998) to increased ability to form metastases. Thus, tumours in
which cells up-regulated VEGF at higher oxygen concentrations
may be more likely to form metastases.
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